ArticleBMC pediatrics2025
Global burden of pediatric fracture (1992-2021) and projections of future disease burden trends.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Article
- Impact of diagnosis-intervention packet payment reform on pediatric hospital services: an interrupted time series analysis.BMC health services research · 2026Article
- Temporal trend of pediatric fracture epidemiology in Thailand: a nationwide study 2018-2024.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
- Enhanced recovery after surgery principles in pediatric fractures and sports injuries: strategies, technologies, and outcomes.Frontiers in pediatrics · 2026Review
- Pediatric fractures in northern China: hospital-based epidemiology and high-risk factors from a regional cohort study.Frontiers in pediatrics · 2026Article
- Global burden and forecast of malignant neoplasms of bone and articular cartilage from 1990 to 2030.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePediatric fracture are a significant public health concern, contributing to both immediate health impacts and long-term disability. This study aims to quantify the burden of pediatric fracture over a 30-year period (1992-2021) and provide forecasts for future disease burden.
methodsComprehensive data on pediatric fracture from 1992 to 2021 were obtained from the Global Burden of Disease study. This dataset includes information on the incidence of pediatric fracture, disaggregated by gender. The Joinpoint regression model was used to identify turning points in epidemiological trends, while decomposition analysis helped identify the factors driving these trends. Health inequalities related to pediatric fracture were assessed using the Slope Index and Concentration Index. To forecast future incidence rates, the Norpred and BAPC models were applied.
resultsThe global ASIR of pediatric fracture was 2225.38 in 1992 and 1531.44 in 2021. The total number of pediatric fracture globally was 39,436,228 in 1992 and 31,033,294 in 2021. The results of the Joinpoint regression indicate a declining trend in the incidence of pediatric fracture globally and in all SDI regions, for both male and female children. Based on the Nordpred and BAPC model, the predicted age-standardized incidence rate for pediatric fracture by 2046 is 1347.61-1349.43. The total number of pediatric fracture predicted by 2046 is 25,048,299-25,123,204.
conclusionOver the past three decades, the global incidence of pediatric fractures has declined. However, population growth has sustained a substantial disease burden, underscoring the necessity for effective prevention and management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.